Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page. This change represents a backend version update and does not modify the study content or results.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a newer ClinicalTrials.gov site revision identifier (v3.5.3 instead of v3.5.2), indicating a minor platform/version update rather than a change to the study record.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 was added, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No study content or functionality is altered.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.4.2 was added and the previous notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.